1. 66. Khoury, , “Beyond Base Pairs,” supra note 25.
2. Return of Genomic Results to Research Participants: The Floor, the Ceiling, and the Choices In Between
3. 70. Compare IOM, Assessing Genomic Sequencing, supra note 40, at 7 (“Exome sequencing can be used for either clinical or research purposes, though recently the boundaries between the two have been blurring. In Hegde's laboratory, exome data are divided according to why the sequencing is being done. For new disease presentations the diagnostic yield, or likelihood that the test will provide enough information to make an appropriate diagnosis, ranges roughly from 30 percent to 40 percent, depending on which laboratory is reporting and what kinds of cases are considered, Hegde said. When writing clinical reports, she said, it is critical to sorting the data into categories of what can be interpreted in the clinic and what is clinically actionable….”).
4. Horizon scanning for translational genomic research beyond bench to bedside